In conclusion, our data suggest that AURKA limits Survivin ubiquitylation and degradation in gastric cancer and provide a novel therapeutic target to promote the efficacy of DNA-damaging agent in gastric cancer. The gene discussed is BIRC5; the disease is gastric cancer.